IP Committee. The Parties will form a committee comprised of representatives of each Party with the requisite expertise in matters involving Patent Rights (the “IP Committee”), which will meet at least [**] (or such other frequency as the Parties mutually agree in writing) to discuss the strategy for, review, and oversee the prosecution, maintenance and enforcement of the AskGene Patent Rights.
Appears in 2 contracts
Sources: Cross License Agreement (Xilio Therapeutics, Inc.), Cross License Agreement (Xilio Therapeutics, Inc.)